US Bancorp DE Acquires 4,089 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

US Bancorp DE increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,065,251 shares of the healthcare conglomerate’s stock after acquiring an additional 4,089 shares during the quarter. UnitedHealth Group comprises about 0.8% of US Bancorp DE’s investment portfolio, making the stock its 25th largest holding. US Bancorp DE’s holdings in UnitedHealth Group were worth $396,351,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Dividend Assets Capital LLC increased its holdings in UnitedHealth Group by 17.0% in the 1st quarter. Dividend Assets Capital LLC now owns 10,236 shares of the healthcare conglomerate’s stock valued at $3,809,000 after buying an additional 1,487 shares during the period. Park Avenue Securities LLC boosted its stake in shares of UnitedHealth Group by 11.7% in the 1st quarter. Park Avenue Securities LLC now owns 25,966 shares of the healthcare conglomerate’s stock valued at $9,661,000 after purchasing an additional 2,721 shares in the last quarter. JJJ Advisors Inc. boosted its stake in shares of UnitedHealth Group by 52.7% in the 1st quarter. JJJ Advisors Inc. now owns 397 shares of the healthcare conglomerate’s stock valued at $148,000 after purchasing an additional 137 shares in the last quarter. Minneapolis Portfolio Management Group LLC boosted its stake in shares of UnitedHealth Group by 1.1% in the 1st quarter. Minneapolis Portfolio Management Group LLC now owns 104,852 shares of the healthcare conglomerate’s stock valued at $39,012,000 after purchasing an additional 1,166 shares in the last quarter. Finally, Lindbrook Capital LLC boosted its stake in shares of UnitedHealth Group by 9.2% in the 1st quarter. Lindbrook Capital LLC now owns 1,473 shares of the healthcare conglomerate’s stock valued at $548,000 after purchasing an additional 124 shares in the last quarter. 86.03% of the stock is currently owned by institutional investors and hedge funds.

In related news, CAO Thomas E. Roos sold 5,301 shares of the business’s stock in a transaction on Tuesday, April 27th. The stock was sold at an average price of $394.66, for a total transaction of $2,092,092.66. Following the completion of the transaction, the chief accounting officer now owns 58,589 shares in the company, valued at approximately $23,122,734.74. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Patricia L. Lewis sold 3,000 shares of the company’s stock in a transaction on Friday, April 16th. The stock was sold at an average price of $389.99, for a total value of $1,169,970.00. Following the completion of the sale, the executive vice president now owns 9,214 shares of the company’s stock, valued at $3,593,367.86. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 20,420 shares of company stock worth $7,532,962. Insiders own 0.80% of the company’s stock.

A number of equities research analysts have recently weighed in on UNH shares. Barclays raised their price target on shares of UnitedHealth Group from $405.00 to $435.00 and gave the company an “overweight” rating in a research note on Thursday, April 22nd. Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $450.00 target price on the stock in a research report on Tuesday, April 27th. Stephens lifted their target price on shares of UnitedHealth Group from $415.00 to $425.00 and gave the stock an “overweight” rating in a research report on Thursday, April 22nd. Mizuho lifted their target price on shares of UnitedHealth Group from $380.00 to $394.00 and gave the stock a “buy” rating in a research report on Thursday, April 15th. Finally, Truist boosted their price target on shares of UnitedHealth Group from $420.00 to $450.00 in a research report on Wednesday, April 14th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $409.61.

UNH traded up $0.61 during trading on Tuesday, reaching $406.51. The stock had a trading volume of 29,765 shares, compared to its average volume of 3,262,127. The stock’s 50 day moving average is $378.48 and its two-hundred day moving average is $349.25. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $383.70 billion, a price-to-earnings ratio of 23.31, a P/E/G ratio of 1.55 and a beta of 0.74. UnitedHealth Group Incorporated has a one year low of $273.71 and a one year high of $406.77.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.38 by $0.93. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The business had revenue of $70.20 billion during the quarter, compared to the consensus estimate of $69.13 billion. During the same quarter in the prior year, the company earned $3.72 earnings per share. The firm’s quarterly revenue was up 9.0% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 16.75 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 23rd. Stockholders of record on Monday, March 15th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.23%. UnitedHealth Group’s payout ratio is currently 33.09%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.

Read More: What is the definition of arbitrage?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.